# FDA Inspection 850881 - Continental Services Group, Inc. - September 27, 2013

Source: https://www.keypedia.com/records/fda_inspections/continental-services-group-inc/c60862af-58f0-4fd0-b6c8-25e4db309788
Source feed: FDA_Inspections

> FDA Inspection 850881 for Continental Services Group, Inc. on September 27, 2013. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 850881
- Company Name: Continental Services Group, Inc.
- Inspection Date: 2013-09-27
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1178109 - 2022-08-24](https://www.keypedia.com/records/fda_inspections/continental-services-group-inc/baad41ec-56c6-4c14-bf27-2532c0bbe7c8)
- [FDA Inspection 1178109 - 2022-08-24](https://www.keypedia.com/records/fda_inspections/continental-services-group-inc/9c1ad310-1843-43b9-9a3f-da019b9bac42)
- [FDA Inspection 1091317 - 2019-05-31](https://www.keypedia.com/records/fda_inspections/continental-services-group-inc/d8e4a6b0-caa9-4ca8-a313-6264ef49c315)
- [FDA Inspection 899467 - 2014-10-01](https://www.keypedia.com/records/fda_inspections/continental-services-group-inc/31e305fb-364d-4a12-838a-bf474b4b9223)
- [FDA Inspection 734288 - 2011-07-14](https://www.keypedia.com/records/fda_inspections/continental-services-group-inc/ba02b5c6-27d7-433a-8690-2454ba183c69)

Company: https://www.keypedia.com/companies/continental-services-group-inc/72358f1d-9b15-4d27-87c5-434e7b5f27d1

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d